Autoantibodies in SLE: Specificities, Isotypes and Receptors
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Systemic Lupus Erythematosus (SLE) is characterized by a wide spectrum of auto-antibodies which recognize several cellular components. The production of these self-reactive antibodies fluctuates during the course of the disease and the involvement of different antibody-secreting cell populations are considered highly relevant for the disease pathogenesis. These cells are developed and stimulated through different ways leading to the secretion of a variety of isotypes, affinities and idiotypes. Each of them has a particular mechanism of action binding to a specific antigen and recognized by distinct receptors. The effector responses triggered lead to a chronic tissue inflammation. DsDNA autoantibodies are the most studied as well as the first in being characterized for its pathogenic role in Lupus nephritis. However, others are of growing interest since they have been associated with other organ-specific damage, such as anti-NMDAR antibodies in neuropsychiatric clinical manifestations or anti-β2GP1 antibodies in vascular symptomatology. In this review, we describe the different auto-antibodies reported to be involved in SLE. How autoantibody isotypes and affinity-binding to their antigen might result in different pathogenic responses is also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34473 · Cited by 5,322
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 1×
“Although, the classical pathway is known to be initiated in an antibody-dependent way (IgM or IgG complexes), C1q molecules can activate complement by recognizing different structures directly on microbial or apoptotic bodies, or through endogenous pattern recognition molecules (PRM) such as immunoglobulins and pentra…”
BackgroundTaming lupus-a new understanding of pathogenesis is leading to clinical advances
Liu, Z., & Davidson, A. (2012) · Nature Medicine · doi:10.1038/nm.2752 · Cited by 433
Wang, H., Li, T., Chen, S., Gu, Y., & Ye, S. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39296 · Cited by 325
Complement fixation with cell nuclei and DNA in lupus erythematosus
Robbins, W. C., Holman, H. R., Deicher, H., & Kunkel, H. G. (1957) · Experimental Biology and Medicine · doi:10.3181/00379727-96-23545 · Cited by 302
A DNA-Reacting Factor in Serum of a Patient with Lupus Erythematosus Diffusus.
Ceppellini, R., Polli, E., & Celada, F. (1957) · Experimental Biology and Medicine · doi:10.3181/00379727-96-23544 · Cited by 249
Lartigue, A., Courville, P., Auquit, I., François, A., Arnoult, C., Tron, F., Gilbert, D., & Musette, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1349 · Cited by 165
Manson, J. J., Ma, A., Rogers, P., Mason, L. J., Berden, J. H., van der Vlag, J., D'Cruz, D. P., Isenberg, D. A., & Rahman, A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2831 · Cited by 129
Murthy, V., Willis, R., Romay‐Penabad, Z., Ruiz‐Limón, P., Martínez‐Martínez, L. A., Jatwani, S., Jajoria, P., Seif, A., Alarcón, G. S., Papalardo, E., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38131 · Cited by 112
Endogenous retroviral pathogenesis in lupus
Perl, A., Fernandez, D., Telarico, T., & Phillips, P. E. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833c6297 · Cited by 75 · cited 1×
“Moreover, anti-HRES-1 antibodies have been associated with SLE predisposition [174].”
Background
Cited by
The role of the host—Neutrophil biology
Chapple, I. L. C., Hirschfeld, J., Kantarci, A., Wilensky, A., & Shapira, L. (2023) · Periodontology 2000 · doi:10.1111/prd.12490 · Cited by 83
Becker, Y. L. C., Gagné, J., Julien, A., Lévesque, T., Allaeys, I., Gougeard, N., Rubio, V., Boisvert, F., Jean, D., Wagner, E., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42082 · Cited by 26
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress
Gjølberg, T. T., Mester, S., Calamera, G., Telstad, J. S., Sandlie, I., & Andersen, J. T. (2025) · BioDrugs · doi:10.1007/s40259-025-00708-2 · Cited by 20
Recent advances in systemic lupus erythematosus and microbiota: from bench to bedside
Zhan, Y., Liu, Q., Zhang, B., Huang, X., & Lu, Q. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0957-7 · Cited by 3
“It involves multiple systems and organs, including the kidney, skin, gastrointestinal tract, and joints [1].”
Background
Metadata
- Authors
- Dema, B., & Charles, N.
- Venue
- Antibodies
- Publisher
- MDPI AG
- Published
- 2016-01-04
- Volume
- 5
- Issue
- 1
- Pages
- 2
- ISSN
- 2073-4468 (ISSN-L)
- OpenAlex
- W2228305902
- Cited by
- 201
- References
- 15
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoantibodies in SLE: Specificities, Isotypes and Receptors. https://app.cochat.ai/papers/10.3390/antib5010002
- The paper
- Dema, B., & Charles, N. (2016). Autoantibodies in SLE: Specificities, Isotypes and Receptors. Antibodies. https://doi.org/10.3390/antib5010002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.